Suppliers / Innopharmax

Innopharmax

Taiwan 27 employees Updated 9 July 2026

Innopharmax is an API manufacturer based in Taiwan. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Gadoteric Acid US FDA 1
Sapropterin US FDA 1

Also appears on these molecule pages

Gadoteric Acid API

Questions about Innopharmax

Does Innopharmax hold a US DMF or a CEP?
Innopharmax holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Innopharmax make?
2 molecules are on record against Innopharmax, including Gadoteric Acid and Sapropterin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Innopharmax comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Biophore India Pharmaceuticals shares 1 molecule Formosa Laboratories shares 1 molecule Jiangsu Hengrui shares 1 molecule Anhui Poly Pharm shares 1 molecule GE Healthcare shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability